The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Dyno Therapeutics has recently announced an exciting collaboration with NVIDIA aimed at leveraging Dynos cuttingedge artificial intelligence and in vivo experimentation prowess alongside NVIDIAs
Arecor Therapeutics plc a biopharmaceutical company focused on advancing therapies for healthier lives has entered a research collaboration with Medtronic plc a global leader in healthcare technology
Siren Biotechnology the pioneers behind Universal AAV ImmunoGene Therapy for Cancer have teamed up with Catalent Inc a renowned provider of advanced treatments worldwide in a strategic collaboration
Sobi has announced that the European Commission has granted approval for an expanded indication for Aspaveli in treating adult patients with paroxysmal nocturnal haemoglobinuria who suffer
ARTBIO Inc a company focused on clinicalstage radiopharmaceutical development specializing
Theragent Inc a prominent Contract Development and Manufacturing Organization specializing in advancing cuttingedge cell and tissuebased therapies has announced a significant collaboration
IRLAB Therapeutics AB has entered into a collaboration with the McQuade Center for Strategic Research and Development LLC a part of the Otsuka pharmaceutical family
Chiesi Farmaceutici SpA also known as Chiesi Group and Gossamer Bio Inc a biopharmaceutical company focused on seralutinib for treating pulmonary hypertension have entered into a global
Eisbach Bio GmbH a privatelyheld biotech company pioneering cancer treatment innovations has reached a significant milestone the United States Food and Drug Administration has cleared
IRLAB Therapeutics AB has recently received approval from the Swedish Medical Products Agency to commence a Phase I clinical trial for their potential treatment for Parkinsons disease
